Fisher & Paykel Healthcare

Home
New Zealand
Auckland
Fisher & Paykel Healthcare

We are a leading designer, manufacturer and marketer of products for use in respiratory care, acute care, and the treatment of obstructive sleep apnea.

Fisher & Paykel commenced business in 1934 as an importer of refrigerators and washing machines. In 1938 F&P started manufacturing white-ware under license to several major international appliance companies and in the mid-1960s moved to manufacturing products using in-house technology. The involvement in healthcare started in the late 1960s when F&P sought involvement in a business that could benefit from their growing manufacturing and electronic expertise. A prototype respiratory humidifier, developed in New Zealand for use with patients needing ventilation in hospital intensive care situations, was taken to production by F&P. Since then we have consistently developed innovations to improve patient care and developed world-wide distribution for these products. On 14 November 2001, as part of a reorganisation, Fisher & Paykel Industries Limited was renamed Fisher & Paykel Healthcare Corporation Limited and a new company, Fisher & Paykel Appliances Holdings Limited, was established to own F&P’s appliances and finance business. In connection with the reorganisation, Fisher & Paykel Healthcare Corporation Limited listed on the Australian and New Zealand Stock Exchanges and NASDAQ. In February 2003 the NASDAQ listing was terminated.

18/12/2025

Heated, humidified respiratory support can benefit infants in many ways and promotes efficient gas exchange. What influences your decision to heat and humidify non-invasive respiratory support in infants and children? Let us know in the poll below then click on the link to read more about the importance of heated humidification, in our special pediatric edition of Flow Matters: https://bit.ly/44wW6FW

What factors influence your decision to heat and humidify non-invasive respiratory support in infants and children?
a. Flow rates
b. Duration of therapy or area of the hospital
c. None of the above – we always heat and humidify
d. Other – please comment below

09/12/2025

Coming soon to the United States: Introducing a PAP* mask designed for top performance, regardless of your preferred sleeping position.

F&P Nova™ Nasal’s SwingFit™ headgear works in synergy with the low-profile RollFit™ cushion, adjusting to movement for a secure seal.

This is performance defined.

Find out more here: https://bit.ly/49BGVyH

27/11/2025

Baby LIV is a neonatal airway simulator that helps clinicians understand how pressure and flow therapies really work.

This simulation tool helps you explore how therapies and interface choice impact tiny lungs. If you are looking to maximize outcomes in your unit, book a Baby LIV session with an F&P Healthcare specialized representative.

Visit our web page to book an in-person session. https://bit.ly/4oz7mtb

26/11/2025

Huge welcome to the 116 interns who joined us this week to work on some exciting and hands-on projects this summer! From engineering to finance, from marketing to supply chain we look forward to seeing you dive deep into the business and help make a difference to millions of patients all over the world.

19/11/2025

Proper mask sizing is crucial for effective neonatal resuscitation. International guidelines recommend that infant face masks should cover the mouth and nose without extending over the chin or covering the eyes.

Research by O'Shea et al. found that 35 mm masks are best for infants under 29 weeks’ gestation, while 42 mm masks suit those aged between 27 and 33 weeks. Explore our full range of neonatal resuscitation masks.

Learn more about our neonatal interfaces and discover the design story of care that goes into making them at https://bit.ly/3ITxQGF

13/11/2025

Behind every great night’s sleep is our commitment to care. Sleep deeply with innovation driven by care.

Curious about great sleep? Find out more at https://bit.ly/4gCA2yH

10/11/2025

A huge thank you to our suppliers for their continued support and collaboration.
This year’s Fisher & Paykel Healthcare Supplier Event brought together nearly 50 of our valued local and international suppliers at our East Tāmaki campus.

It was fantastic to welcome them onsite, where they had the opportunity to connect face-to-face with our teams—reinforcing the theme of the event: Collaboration.

Our suppliers gained insights into F&P’s strategic direction from senior leaders, and we proudly acknowledged their contributions in helping us achieve these goals. The Supplier Expo was once again a highlight, showcasing a wide range of products and capabilities to the wider business.

We remain committed to building strong, long-term partnerships with our suppliers—because together, we create better outcomes for patients around the world.

06/11/2025

We are excited to continue our educational journey with The Incubator Podcast on the “CPAP with Purpose” series – a podcast dedicated to supporting babies in the delivery room and NICU through thoughtful respiratory care.

Episode three, “Tech Tuesday,” dives into an often-misunderstood topic – condensate in humidified respiratory support.

F&P Healthcare general manager and engineer, Laurence Gulliver, shares: ‘Condensate isn’t a sign of excess humidity — it’s actually lost humidity. When condensate forms, it’s not just a management burden; it means the patient isn’t receiving optimal humidity.’

This episode explores how understanding and managing condensate can improve outcomes and reduce stress for caregivers. https://bit.ly/3JjLToW

04/11/2025

Using the F&P 950™ system*, trial nasal high flow therapy with the F&P Optiflow™ Junior 2 transition kits. Transition your patient on invasive ventilation or CPAP therapy to nasal high flow by removing the expiratory limb and attaching the ventilator transition kit or blender transition kit to the inspiratory limb and set your desired flow rate.

Explore the Optiflow Junior 2 range for delivery of nasal high flow therapy to neonates, infants and children. https://bit.ly/3IQGmFQ

This product is not available for purchase by the general public. Always follow the directions for use.

03/11/2025

T-piece resuscitators deliver consistent and controlled peak end expiratory pressure (PEEP), the residual pressure maintained at the end of expiration. Research suggests that adequate levels of PEEP may help to establish and maintain functional residual capacity (FRC) during transition at birth.

This illustration shows the waveforms generated during positive pressure ventilation with a T-piece resuscitator (purple waveform) and a self-inflating bag without a PEEP valve (blue waveform). The provision of adequate and consistent PEEP, as can be achieved with a T-piece resuscitator, prevents the collapse of alveoli at the end of expiration thereby helping to establish and maintain FRC.

Click to learn more about T-piece resuscitation: https://bit.ly/3JmKYUw

Address

15 Maurice Paykel Place, East Tamaki
Auckland
2013

Telephone

+64 9 574 0100

Website

https://www.fphcare.com/

Alerts

Be the first to know and let us send you an email when Fisher & Paykel Healthcare posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Want your practice to be the top-listed Clinic in Auckland?